Statement Of Income And Retained Earnings

Astellas Pharma Inc. - Filing #7604918

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
105,929,000,000 JPY
91,917,000,000 JPY
Non-operating income
Non-operating income
165,666,000,000 JPY
132,197,000,000 JPY
Non-operating expenses
Non-operating expenses
1,051,000,000 JPY
681,000,000 JPY
Ordinary profit (loss)
270,544,000,000 JPY
223,433,000,000 JPY
Extraordinary income
Extraordinary income
5,150,000,000 JPY
532,000,000 JPY
Extraordinary losses
Extraordinary losses
21,561,000,000 JPY
5,069,000,000 JPY
Profit (loss) before income taxes
254,133,000,000 JPY
218,896,000,000 JPY
Income taxes - current
35,204,000,000 JPY
5,036,000,000 JPY
Income taxes - deferred
-6,166,000,000 JPY
20,805,000,000 JPY
Profit (loss)
225,095,000,000 JPY
JPY
JPY
JPY
225,095,000,000 JPY
225,095,000,000 JPY
JPY
JPY
225,095,000,000 JPY
JPY
JPY
JPY
JPY
JPY
193,055,000,000 JPY
JPY
JPY
JPY
JPY
JPY
193,055,000,000 JPY
193,055,000,000 JPY
JPY
193,055,000,000 JPY
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.